TABLE 4.
Antimicrobial susceptibility of Aeromonas isolates from humans and fisha
| Drug | No. (%) of susceptible isolates or susceptibility |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
A. dhakensis |
A. hydrophila |
A. caviae |
A. veronii |
A. bivalvium | A. enteropelogenes |
A. taiwanensis |
A. media | A. jandaei | A. salmonicida | A. schubertii | ||||||
| Fish (n = 10) | Human (n = 14) | Fish (n = 10) | Human (n = 6) | Fish (n = 43) | Human (n = 14) | Fish (n = 33) | Human (n = 11) | Fish (n = 13) | Fish (n = 6) | Fish (n = 6) | Human (n = 1) | Fish (n = 4) | Fish (n = 1) | Fish (n = 2) | Human (n = 1) | |
| AM | 2 (20) | 0 | 0 | 0 | 0 | 0 | 1 (3.0) | 0 | 0 | 4 (66.7) | 0 | R | 0 | R | 0 | R |
| SAM | 2 (20) | 0 | 0 | 0 | 4 (9.3) | 0 | 1 (3.0) | 0 | 0 | 5 (83.3) | 0 | R | 0 | R | 0 | R |
| PIP | 9 (90) | 12 (85.7) | 9 (90) | 3 (50) | 37 (86.0) | 11 (78.6) | 28 (84.8) | 10 (90.9) | 10 (76.9) | 6 (100) | 5 (83.3) | S | 3 (75.0) | S | 2 (100) | S |
| TZP | 10 (100) | 12 (85.7) | 10 (100) | 6 (100) | 42 (97.7) | 12 (85.7) | 32 (97.0) | 11 (100) | 13 (100) | 6 (100) | 5 (83.3) | S | 3 (75.0) | R | 2 (100) | S |
| CZ | 0 | 0 | 0 | 0 | 2 (4.7) | 0 | 17 (51.5) | 0 | 0 | 2 (33.3) | 0 | R | 0 | I | 0 | I |
| CXM | 10 (100) | 12 (85.7) | 10 (100) | 3 (50) | 43 (100) | 10 (71.4) | 33 (100) | 11 (100) | 13 (100) | 6 (100) | 6 (100) | I | 4 (100) | S | 2 (100) | S |
| CTX | 10 (100) | 12 (85.7) | 10 (100) | 3 (50) | 43 (100) | 10 (71.4) | 33 (100) | 11 (100) | 13 (100) | 6 (100) | 6 (100) | I | 4 (100) | S | 2 (100) | S |
| CAZ | 10 (100) | 12 (85.7) | 10 (100) | 3 (50) | 43 (100) | 11 (78.6) | 33 (100) | 11 (100) | 13 (100) | 6 (100) | 6 (100) | S | 4 (100) | S | 2 (100) | S |
| FEP | 10 (100) | 14 (100) | 10 (100) | 6 (100) | 43 (100) | 13 (92.9) | 33 (100) | 11 (100) | 13 (100) | 6 (100) | 6 (100) | S | 4 (100) | S | 2 (100) | S |
| ATM | 10 (100) | 14 (100) | 10 (100) | 5 (83.3) | 43 (100) | 12 (85.7) | 33 (100) | 11 (100) | 13 (100) | 6 (100) | 6 (100) | S | 4 (100) | S | 2 (100) | S |
| ETP | 10 (100) | 12 (85.7) | 10 (100) | 6 (100) | 43 (100) | 13 (92.9) | 30 (90.9) | 9 (81.8) | 13 (100) | 6 (100) | 6 (100) | S | 4 (100) | S | 2 (100) | S |
| IMP | 10 (100) | 12 (85.7) | 10 (100) | 6 (100) | 43 (100) | 14 (100) | 33 (100) | 10 (90.9) | 13 (100) | 6 (100) | 6 (100) | S | 4 (100) | S | 2 (100) | S |
| LVX | 10 (100) | 14 (100) | 10 (100) | 5 (83.3) | 43 (100) | 13 (92.9) | 33 (100) | 11 (100) | 13 (100) | 6 (100) | 6 (100) | S | 4 (100) | S | 2 (100) | S |
| GM | 10 (100) | 14 (100) | 9 (100) | 6 (100) | 43 (100) | 13 (92.9) | 33 (100) | 11 (100) | 13 (100) | 6 (100) | 6 (100) | S | 4 (100) | S | 2 (100) | S |
| AN | 10 (100) | 14 (100) | 10 (100) | 5 (83.3) | 43 (100) | 14 (100) | 33 (100) | 11 (100) | 13 (100) | 6 (100) | 6 (100) | S | 4 (100) | S | 2 (100) | S |
| SXT | 0 | 13 (92.9) | 1 (10) | 6 (100) | 3 (7.0) | 8 (57.1) | 5 (15.1) | 11 (100) | 1 (7.7) | 2 (33.3) | 3 (50) | S | 0 | I | 1 (50) | S |
| DXY | 10 (100) | 14 (100) | 9 (90) | 6 (100) | 40 (93.0) | 13 (92.9) | 31 (93.9) | 11 (100) | 13 (100) | 6 (100) | 6 (100) | S | 4 (100) | S | 2 (100) | S |
| TET | 9 (90) | 7 (50) | 7 (70) | 5 (83.3) | 36 (83.7) | 11 (78.6) | 17 (51.5) | 8 (72.7) | 13 (100) | 6 (100) | 5 (83.3) | S | 4 (100) | S | 2 (100) | S |
a
AM, ampicillin; SAM, ampicillin-sulbactam; PIP, piperacillin; TZP, piperacillin-tazobactam; CZ, cefazolin; CXM, cefuroxime; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; ATM, aztreonam; ETP, ertapenem; IMP, imipenem; LVX, levofloxacin; GM, gentamicin; AN, amikacin; SXT, co-trimoxazole; DXY, doxycycline; TET, tetracycline; S, susceptible; I, intermediate; R, resistant.